Effect of switching to teneligliptin from other dipeptidyl peptidase‐4 inhibitors on glucose control and renoprotection in type 2 diabetes patients with diabetic kidney disease. - Kitada, Munehiro; Ogura, Yoshio; Nitta, Kyoko; Fujii, Mizue; Kanasaki, Keizo; Konishi, Kazunori; Iida, Yasuo; Nakagawa, Atsushi; Koya, Daisuke (Journal of Diabetes Investigation, 2019)